|
| 37777995 | Loss of Upk1a and Upk1b expression is linked to stage progression in urothelial carcinoma of the bladder. | Int Urol Nephrol | 2024 |
| 35946088 | Pan-keratin Immunostaining in Human Tumors: A Tissue Microarray Study of 15,940 Tumors. | Int J Surg Pathol | 2023 |
| 37892063 | Diagnostic Role and Prognostic Impact of PSAP Immunohistochemistry: A Tissue Microarray Study on 31,358 Cancer Tissues. | Diagnostics (Basel) | 2023 |
| 37938166 | Altered p53/p16 expression is linked to urothelial carcinoma progression but largely unrelated to prognosis in muscle-invasive tumors. | Acta Oncol | 2023 |
| 37379306 | CELA3B immunostaining is a highly specific marker for acinar cell carcinoma of the pancreas. | PLoS One | 2023 |
| 36997051 | Cytokeratin 20 expression is linked to stage progression and to poor prognosis in advanced (pT4) urothelial carcinoma of the bladder. | Exp Mol Pathol | 2023 |
| 36683495 | PD-L1 expression and CD8 positive lymphocytes in human neoplasms: A tissue microarray study on 11,838 tumor samples. | Cancer Biomark | 2023 |
| 36269681 | Cytokeratin 13 (CK13) expression in cancer: a tissue microarray study on 10,439 tumors. | APMIS | 2023 |
| 35917493 | SATB2 Expression in Human Tumors: A Tissue Microarray Study on More Than 15â¿¿000 Tumors. | Arch Pathol Lab Med | 2023 |
| 33414516 | CHD1 loss negatively influences metastasis-free survival in R0-resected prostate cancer patients and promotes spontaneous metastasis in vivo. | Cancer Gene Ther | 2022 |
| 35764407 | Mucin 5AC expression is common but unrelated to tumor progression in pancreatic adenocarcinoma. | Int J Immunopathol Pharmacol | 2022 |
| 35642329 | DOG1 overexpression is associated with mismatch repair deficiency and BRAF mutations but unrelated to cancer progression in colorectal cancer. | Histol Histopathol | 2022 |
| 35390310 | Cytokeratin 7 and cytokeratin 20 expression in cancer: A tissue microarray study on 15,424 cancers. | Exp Mol Pathol | 2022 |
| 35862385 | High prevalence of p16 staining in malignant tumors. | PLoS One | 2022 |
| 35449481 | Correction to: MMR Deficiency is Homogeneous in Pancreatic Carcinoma and Associated with High Density of Cd8-Positive Lymphocytes. | Ann Surg Oncol | 2022 |
| 36137400 | Diagnostic and prognostic role of pancreatic secretory granule membrane major glycoprotein 2 (GP2) immunohistochemistry: A TMA study on 27,681 tumors. | Pathol Res Pract | 2022 |
| 35866621 | Villin expression in human tumors: a tissue microarray study on 14,398 tumors. | Expert Rev Mol Diagn | 2022 |
| 36029589 | Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumors. | Ann Diagn Pathol | 2022 |
| 36292206 | Analysis of More than 16,000 Human Tumor and Normal Tissues Identifies Uroplakin 3B as a Useful Diagnostic Marker for Mesothelioma and Normal Mesothelial Cells. | Diagnostics (Basel) | 2022 |
| 36152841 | GATA3 expression loss is linked to stage progression but is unrelated to prognosis in muscle-invasive urothelial carcinoma of the bladder. | Hum Pathol | 2022 |
| 36375372 | Desmoglein 3 (Dsg3) expression in cancer: A tissue microarray study on 15,869 tumors. | Pathol Res Pract | 2022 |
| 34889867 | Carboxypeptidase A1 (CPA1) Immunohistochemistry Is Highly Sensitive and Specific for Acinar Cell Carcinoma (ACC) of the Pancreas. | Am J Surg Pathol | 2022 |
| 34625909 | 6q deletion is frequent but unrelated to patient prognosis in breast cancer. | Breast Cancer | 2022 |
| 34559291 | Cytokeratin 5 and cytokeratin 6 expressions are unconnected in normal and cancerous tissues and have separate diagnostic implications. | Virchows Arch | 2022 |
| 32303902 | High level of EZH2 expression is linked to high density of CD8-positive T-lymphocytes and an aggressive phenotype in renal cell carcinoma. | World J Urol | 2021 |
| 33797012 | Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer. | Int Urol Nephrol | 2021 |
| 33494829 | p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors. | Biomark Res | 2021 |
| 33708836 | Y-chromosome loss is frequent in male renal tumors. | Ann Transl Med | 2021 |
| 33588765 | Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors. | Mol Med | 2021 |
| 33917081 | Mesothelin Expression in Human Tumors: A Tissue Microarray Study on 12,679 Tumors. | Biomedicines | 2021 |
| 34944647 | Angiotensin-Converting Enzyme 2 Protein Is Overexpressed in a Wide Range of Human Tumour Types: A Systematic Tissue Microarray Study on >15,000 Tumours. | Biomedicines | 2021 |
| 34547930 | MUC5AC Expression in Various Tumor Types and Nonneoplastic Tissue: A Tissue Microarray Study on 10â¿¿399 Tissue Samples. | Technol Cancer Res Treat | 2021 |
| 34462659 | High mitochondrial content is associated with breast cancer aggressiveness. | Mol Clin Oncol | 2021 |
| 34425503 | Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin. | Ann Diagn Pathol | 2021 |
| 34717148 | DOG1 expression is common in human tumors: A tissue microarray study on more than 15,000 tissue samples. | Pathol Res Pract | 2021 |
| 34414034 | DOG1 is commonly expressed in pancreatic adenocarcinoma but unrelated to cancer aggressiveness. | PeerJ | 2021 |
| 34102222 | Diagnostic and prognostic impact of cytokeratin 19 expression analysis in human tumors: a tissue microarray study of 13,172 tumors. | Hum Pathol | 2021 |
| 34092167 | High density of cytotoxic T-lymphocytes is linked to tumoral PD-L1 expression regardless of the mismatch repair status in colorectal cancer. | Acta Oncol | 2021 |
| 34363325 | Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors. | J Pathol Clin Res | 2021 |
| 34090526 | E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors. | Biomark Res | 2021 |
| 34257582 | Napsin A Expression in Human Tumors and Normal Tissues. | Pathol Oncol Res | 2021 |
| 33373033 | Elevated MUC5AC expression is associated with mismatch repair deficiency and proximal tumor location but not with cancer progression in colon cancer. | Med Mol Morphol | 2021 |
| 33045100 | Chromosome 5 harbors two independent deletion hotspots at 5q13 and 5q21 that characterize biologically different subsets of aggressive prostate cancer. | Int J Cancer | 2021 |
| 32361874 | A non-diploid DNA status is linked to poor prognosis in renal cell cancer. | World J Urol | 2021 |
| 32256975 | Loss of p16 and high Ki67 labeling index is associated with poor outcome in esophageal carcinoma. | Oncotarget | 2020 |
| 31757738 | 8p deletions in renal cell carcinoma are associated with unfavorable tumor features and poor overall survival. | Urol Oncol | 2020 |
| 31811435 | High homogeneity of mismatch repair deficiency in advanced prostate cancer. | Virchows Arch | 2020 |
| 32076485 | Prevalence and clinical significance of VHL mutations and 3p25 deletions in renal tumor subtypes. | Oncotarget | 2020 |
| 31924330 | High homogeneity of MMR deficiency in ovarian cancer. | Gynecol Oncol | 2020 |
| 31745645 | Claudin-1 upregulation is associated with favorable tumor features and a reduced risk for biochemical recurrence in ERG-positive prostate cancer. | World J Urol | 2020 |